Yongmei Xie

About Yongmei Xie

Yongmei Xie, With an exceptional h-index of 33 and a recent h-index of 25 (since 2020), a distinguished researcher at Sichuan University, specializes in the field of Protacs, PET/CT Tracer, Oncology, Medicinal chemistry, Fluorescent probes.

His recent articles reflect a diverse array of research interests and contributions to the field:

Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment

Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii

A Novel HPLC Method for Quality Inspection of NRK Biosynthesized β-Nicotinamide Mononucleotide

Synthesis and in vitro anti-tumor evaluation of novel glycoconjugated SN38 derivatives

Low-dose Cu exposure enhanced α-synuclein accumulation associates with mitochondrial impairments in mice model of Parkinson's disease

Multiomics analysis of human peripheral blood reveals marked molecular profiling changes caused by one night of sleep deprivation

Synthesis and biological evaluation of novel SN38-glucose conjugate for colorectal cancer treatment

An overview of PROTACs: a promising drug discovery paradigm

Yongmei Xie Information

University

Position

State Key Laboratory of Biotherapy

Citations(all)

3298

Citations(since 2020)

2000

Cited By

2144

hIndex(all)

33

hIndex(since 2020)

25

i10Index(all)

74

i10Index(since 2020)

57

Email

University Profile Page

Google Scholar

Yongmei Xie Skills & Research Interests

Protacs

PET/CT Tracer

Oncology

Medicinal chemistry

Fluorescent probes

Top articles of Yongmei Xie

Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment

Frontiers in Pharmacology

2024/4/19

Xingxing Wang
Xingxing Wang

H-Index: 2

Yongmei Xie
Yongmei Xie

H-Index: 22

Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii

Journal of Nanobiotechnology

2024/3/30

A Novel HPLC Method for Quality Inspection of NRK Biosynthesized β-Nicotinamide Mononucleotide

Journal of Chromatographic Science

2024/3

Yongmei Xie
Yongmei Xie

H-Index: 22

Synthesis and in vitro anti-tumor evaluation of novel glycoconjugated SN38 derivatives

Chemistry Letters

2023/10/5

Low-dose Cu exposure enhanced α-synuclein accumulation associates with mitochondrial impairments in mice model of Parkinson's disease

Toxicology Letters

2023/9/15

Multiomics analysis of human peripheral blood reveals marked molecular profiling changes caused by one night of sleep deprivation

MedComm

2023/6

Synthesis and biological evaluation of novel SN38-glucose conjugate for colorectal cancer treatment

Bioorganic & medicinal chemistry letters

2023/2/1

An overview of PROTACs: a promising drug discovery paradigm

2022/12/20

Discovery of potent and selective HER2 PROTAC degrader based Tucatinib with improved efficacy against HER2 positive cancers

European Journal of Medicinal Chemistry

2022/12/15

Jiaxuan Li
Jiaxuan Li

H-Index: 2

Yongmei Xie
Yongmei Xie

H-Index: 22

Discovery of highly potent and selective 7-ethyl-10-hydroxycamptothecin-glucose conjugates as potential anti-colorectal cancer agents

Frontiers in Pharmacology

2022/11/23

Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma

Scientific Reports

2022/6/28

Design, Synthesis, and Biological Evaluation of Novel Pyrrolo [2, 3-b] Pyridine Derivatives for Nonalcoholic Fatty Liver Disease

Future Journal of Pharmaceutical Sciences

2015/6/1

A Case of Congenital Tufting Enteropathy with EpCAM Gene Complex Heterozygous Mutation (c.491+1G>A; c.352_353ins CACC)

JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES)

2022/5/20

Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study

Respiratory Research

2022/2/16

Mitochondriomics reveals the underlying neuroprotective mechanism of TrkB receptor agonist R13 in the 5× FAD mice

Neuropharmacology

2022/2/15

Novel lysosome-targeted anticancer fluorescent agents used in zebrafish and nude mouse tumour imaging

Frontiers of Chemical Science and Engineering

2022/1/1

SIS3, a good candidate for the reverse of type 2 diabetes mellitus in mice

Fundamental & Clinical Pharmacology

2021/4

A pyridine-Si-rhodamine-based near-infrared fluorescent probe for visualizing reactive oxygen species in living cells

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy

2021/2/5

R13 preserves motor performance in SOD1G93A mice by improving mitochondrial function

Theranostics

2021

Identification of hub lncRNAs along with lncRNA-miRNA-mRNA network for effective diagnosis and prognosis of papillary thyroid cancer

Frontiers in Pharmacology

2021/10/13

See List of Professors in Yongmei Xie University(Sichuan University)

Co-Authors

academic-engine